Synopsis A recent clinical study demonstrates the efficacy and safety of Dupilumab in patients with Moderate-to-Severe Uncontrolled Asthma. The present study aims to assess the efficacy and safety of Dupilumab in patients with uncontrolled asthma. This week’s “MED FACT” discusses a clinical trial from The New England Journal of Medicine, “ Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma ” . May, 2018. Authors : M. Castro; J.
Corren; I.D.Pavord; et. al. Key Takeaways: Dupilumab showed an improvement in the rate of severe exacerbations, lung function and uncontrolled Asthma. Objective: To evaluate the efficacy and safety of Dupilumab in patients with Moderate-to-Severe Uncontrolled Asthma Study Type: Randomized, Double-blind, placebo-controlled, parallel-group study Participants: 1902 What was the need for this study? Dupilumab has been approved for the…
